Drug
Sirolimus
Sirolimus: highest development phase Phase 2/3, developed by Pfizer. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sirolimus NCT03047980 | Phase 2/3 | Sturge-Weber Syndrome |
| Sirolimus NCT01680250 | Phase 2/3 | Polycystic Kidney Diseases |
Latest
No recent events.
Follow Sirolimus on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.